These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 29147928

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma.
    Cen P, Hofstetter WL, Correa AM, Wu TT, Lee JH, Ross WA, Davilla M, Swisher SG, Fukami N, Rashid A, Maru D, Ajani JA.
    Cancer; 2008 Mar 01; 112(5):1020-7. PubMed ID: 18205187
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease.
    Schölvinck D, Künzli H, Meijer S, Seldenrijk K, van Berge Henegouwen M, Bergman J, Weusten B.
    Surg Endosc; 2016 Sep 01; 30(9):4102-13. PubMed ID: 27357927
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Predicting lymph node metastases in early esophageal adenocarcinoma using a simple scoring system.
    Lee L, Ronellenfitsch U, Hofstetter WL, Darling G, Gaiser T, Lippert C, Gilbert S, Seely AJ, Mulder DS, Ferri LE.
    J Am Coll Surg; 2013 Aug 01; 217(2):191-9. PubMed ID: 23659947
    [Abstract] [Full Text] [Related]

  • 7. Treatment trends, risk of lymph node metastasis, and outcomes for localized esophageal cancer.
    Merkow RP, Bilimoria KY, Keswani RN, Chung J, Sherman KL, Knab LM, Posner MC, Bentrem DJ.
    J Natl Cancer Inst; 2014 Jul 01; 106(7):. PubMed ID: 25031273
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens.
    Leers JM, DeMeester SR, Oezcelik A, Klipfel N, Ayazi S, Abate E, Zehetner J, Lipham JC, Chan L, Hagen JA, DeMeester TR.
    Ann Surg; 2011 Feb 01; 253(2):271-8. PubMed ID: 21119508
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Lymph node metastasis and prognostic factors for T1 esophageal cancer].
    Duan XF, Shang XB, Tang P, Jiang HJ, Gong L, Yue J, Ma MQ, Yu ZT.
    Zhonghua Wai Ke Za Zhi; 2017 Sep 01; 55(9):690-695. PubMed ID: 28870055
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Using the National Cancer Database to create a scoring system that identifies patients with early-stage esophageal cancer at risk for nodal metastases.
    Weksler B, Kennedy KF, Sullivan JL.
    J Thorac Cardiovasc Surg; 2017 Nov 01; 154(5):1787-1793. PubMed ID: 28867381
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinicopathologic factors predicting lymph node metastasis in superficial esophageal squamous cell carcinoma.
    Moon JY, Kim GH, Kim JH, Kim HH, Ryu KD, Park SO, Lee BE, Song GA.
    Scand J Gastroenterol; 2014 May 01; 49(5):589-94. PubMed ID: 24641315
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.